Literature DB >> 2021543

Frequency and mechanism of Lewis antigen expression in human urinary bladder and colon carcinoma patients.

N C Langkilde1, H Wolf, P Meldgård, T F Orntoft.   

Abstract

Changes in the expression of Lewis antigens have been associated with cancer diseases, and recent results have pointed at a possible increased risk of cancer development among Lewis negative patients. The frequency of the erythrocyte Lewis phenotypes Le(a- b+), Le(a+ b-) and Le(a- b-) was analysed in patients suffering from urinary bladder cancer (82), colon cancer (21), and benign urological diseases (45). An increased frequency of Lewis negative individuals was found among colon cancer patients (P less than 0.004) and bladder cancer patients (P = 0.05). The Lewis negative phenotype was shown to be associated with unfavourable disease parameters: invasion (P less than 0.02) and high grade of atypia (P less than 0.01) in bladder cancer patients, and high Dukes stage (P less than 0.05) in colon cancer patients. alpha 1-4fucosyltransferase activity (Lewis transferase) was shown to be present in saliva from four out of eight erythrocyte Lewis negative cancer patients, indicating that some patients with advanced cancer disease may have converted from a Lewis positive to a Lewis negative phenotype.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2021543      PMCID: PMC1972368          DOI: 10.1038/bjc.1991.135

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  Adsorption of blood-group substances from serum on to red cells.

Authors:  J S SNEATH; P H SNEATH
Journal:  Br Med Bull       Date:  1959-05       Impact factor: 4.291

2.  Cancer-associated alterations of blood group antigen expression in human colorectal polyps.

Authors:  S H Itzkowitz; M Yuan; L D Ferrell; A Palekar; Y S Kim
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

3.  Loss of Lewis antigen expression on erythrocytes in some cancer patients with high serum CA19-9 levels.

Authors:  K Hirano; S Kawa; H Oguchi; T Kobayashi; H Yonekura; H Ogata; T Homma
Journal:  J Natl Cancer Inst       Date:  1987-12       Impact factor: 13.506

4.  Glycosphingolipids with Lewis blood group activity: uptake by human erythrocytes.

Authors:  D M Marcus; L E Cass
Journal:  Science       Date:  1969-05-02       Impact factor: 47.728

5.  Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years.

Authors:  A Bergkvist; A Ljungqvist; G Moberger
Journal:  Acta Chir Scand       Date:  1965-10

6.  An enzymatic basis for secretor status and blood group substance specificity in humans.

Authors:  L Shen; E F Grollman; V Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  1968-01       Impact factor: 11.205

7.  Molecular and genetic aspects of human blood-group Le-b specificity.

Authors:  A M Marr; A S Donald; W M Watkins; W T Morgan
Journal:  Nature       Date:  1967-09-23       Impact factor: 49.962

8.  Blood group lewis phenotype on erythrocytes and in saliva in alcoholic pancreatitis and chronic liver disease.

Authors:  L Stigendal; R Olsson; L Rydberg; B E Samuelsson
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

9.  ABH and Lewis blood group expression in colorectal carcinoma.

Authors:  R Schoentag; F J Primus; W Kuhns
Journal:  Cancer Res       Date:  1987-03-15       Impact factor: 12.701

10.  An enzymatic basis for Lewis blood types in man.

Authors:  E F Grollman; A Kobata; V Ginsburg
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

View more
  3 in total

Review 1.  Circulating blood group related carbohydrate antigens as tumour markers.

Authors:  T F Orntoft; E Bech
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

2.  CD10 and CA19.9 immunohistochemical expression in transitional cell carcinoma of the urinary bladder.

Authors:  Ahmed Salahaldeen Mohammed; Husam Hasson Ali; Ban Jumaa Qasim; Mohammed Kassim Chaloob
Journal:  Urol Ann       Date:  2013-04

3.  Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma.

Authors:  Y T van der Schouw; A L Verbeek; T Wobbes; M F Segers; C M Thomas
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.